Virus-Specific Regulatory T Cells Ameliorate Encephalitis by Repressing Effector T Cell Functions from Priming to Effector Stages

English version České info

By repressing immune responses against pathogens, regulatory CD4 T cells are double edged swords. On one hand, they ameliorate immunopathological disease, diminishing morbidity but they also potentially contribute to pathogen persistence. Tregs have long been thought to be primarily directed at self-antigens, but we and others recently demonstrated the presence of pathogen-specific Tregs in infected animals. As is true for all pathogen-specific Tregs, few details are known about how these cells suppress T cell responses, especially those responding to the cognate epitope. Here, using mice with encephalitis caused by neurotropic coronavirus, we analyzed and compared the very earliest steps in the priming, proliferation and differentiation of Treg and Tconv responding to the same epitope, thereby providing new, fundamental information about these processes. Further, we identify a new role for pathogen epitope-specific Tregs in an acute infectious disease with an immunopathological component. Compared to bulk Tregs, they have the advantage of specifically diminishing numbers and function of pathogenic CD4 T cells responding to the same epitope without suppressing the anti-virus T cell response. Their use in the context of encephalitis or other infections would allow targeting of pathogenic CD4 T cell responses without generally suppressing the protective components of the immune response.

Vyšlo v časopise: Virus-Specific Regulatory T Cells Ameliorate Encephalitis by Repressing Effector T Cell Functions from Priming to Effector Stages. PLoS Pathog 10(8): e32767. doi:10.1371/journal.ppat.1004279
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1004279

Souhrn

Zdroje

1. VignaliDA, CollisonLW, WorkmanCJ (2008) How regulatory T cells work. Nat Rev Immunol 8 : 523–532.

2. LundJM, HsingL, PhamTT, RudenskyAY (2008) Coordination of early protective immunity to viral infection by regulatory T cells. Science 320 : 1220–1224.

3. RuckwardtTJ, BonaparteKL, NasonMC, GrahamBS (2009) Regulatory T cells promote early influx of CD8+ T cells in the lungs of respiratory syncytial virus-infected mice and diminish immunodominance disparities. J Virol 83 : 3019–3028.

4. Veiga-PargaT, SehrawatS, RouseBT (2013) Role of regulatory T cells during virus infection. Immunol Rev 255 : 182–196.

5. LanteriMC, O'BrienKM, PurthaWE, CameronMJ, LundJM, et al. (2009) Tregs control the development of symptomatic West Nile virus infection in humans and mice. J Clin Invest 119 : 3266–3277.

6. SuvasS, AzkurAK, KimBS, KumaraguruU, RouseBT (2004) CD4+CD25+ regulatory T cells control the severity of viral immunoinflammatory lesions. J Immunol 172 : 4123–4132.

7. TrandemK, AnghelinaD, ZhaoJ, PerlmanS (2010) Regulatory T cells inhibit T cell proliferation and decrease demyelination in mice chronically infected with a coronavirus. J Immunol 184 : 4391–4400.

8. AnghelinaD, ZhaoJ, TrandemK, PerlmanS (2009) Role of regulatory T cells in coronavirus-induced acute encephalitis. Virology 385 : 358–367.

9. Veiga-PargaT, SuryawanshiA, MulikS, GimenezF, SharmaS, et al. (2012) On the role of regulatory T cells during viral-induced inflammatory lesions. J Immunol 189 : 5924–5933.

10. BedoyaF, ChengGS, LeibowA, ZakharyN, WeisslerK, et al. (2013) Viral antigen induces differentiation of Foxp3+ natural regulatory T cells in influenza virus-infected mice. J Immunol 190 : 6115–6125.

11. SuffiaIJ, RecklingSK, PiccirilloCA, GoldszmidRS, BelkaidY (2006) Infected site-restricted Foxp3+ natural regulatory T cells are specific for microbial antigens. J Exp Med 203 : 777–788.

12. ZhaoJ, ZhaoJ, FettC, TrandemK, FlemingE, et al. (2011) IFN-gamma -⁠ and IL-10-expressing virus epitope-specific Foxp3(+) T reg cells in the central nervous system during encephalomyelitis. J Exp Med 208 : 1571–1577.

13. ShafianiS, DinhC, ErteltJM, MogucheAO, SiddiquiI, et al. (2013) Pathogen-specific Treg cells expand early during mycobacterium tuberculosis infection but are later eliminated in response to Interleukin-12. Immunity 38 : 1261–1270.

14. JohannsTM, ErteltJM, RoweJH, WaySS (2010) Regulatory T cell suppressive potency dictates the balance between bacterial proliferation and clearance during persistent Salmonella infection. PLoS Pathog 6: e1001043.

15. MoonJJ, DashP, OguinTH3rd, McClarenJL, ChuHH, et al. (2011) Quantitative impact of thymic selection on Foxp3+ and Foxp3 −⁠ subsets of self-peptide/MHC class II-specific CD4+ T cells. Proc Natl Acad Sci U S A 108 : 14602–14607.

16. BelkaidY, OldenhoveG (2008) Tuning microenvironments: induction of regulatory T cells by dendritic cells. Immunity 29 : 362–371.

17. TangQ, HenriksenKJ, BiM, FingerEB, SzotG, et al. (2004) In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J Exp Med 199 : 1455–1465.

18. TarbellKV, PetitL, ZuoX, ToyP, LuoX, et al. (2007) Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice. J Exp Med 204 : 191–201.

19. ShafianiS, Tucker-HeardG, KariyoneA, TakatsuK, UrdahlKB (2010) Pathogen-specific regulatory T cells delay the arrival of effector T cells in the lung during early tuberculosis. J Exp Med 207 : 1409–1420.

20. BergmannCC, LaneTE, StohlmanSA (2006) Coronavirus infection of the central nervous system: host-virus stand-off. Nat Rev Microbiol 4 : 121–132.

21. CampbellDJ, KochMA (2011) Phenotypical and functional specialization of FOXP3+ regulatory T cells. Nat Rev Immunol 11 : 119–130.

22. KochMA, Tucker-HeardG, PerdueNR, KillebrewJR, UrdahlKB, et al. (2009) The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nat Immunol 10 : 595–602.

23. ZhaoJ, FettC, PeweL, ZhaoJ, PerlmanS (2013) Development of transgenic mice expressing a coronavirus-specific public CD4 T cell receptor. J Immunol Methods 396 : 56–64.

24. LiuMT, ChenBP, OertelP, BuchmeierMJ, ArmstrongD, et al. (2000) The T cell chemoattractant IFN-inducible protein 10 is essential in host defense against viral-induced neurologic disease. J Immunol 165 : 2327–2330.

25. BrinkmannV, BillichA, BaumrukerT, HeiningP, SchmouderR, et al. (2010) Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis. Nat Rev Drug Discov 9 : 883–897.

26. BeimaKM, MiazgowiczMM, LewisMD, YanPS, HuangTH, et al. (2006) T-bet binding to newly identified target gene promoters is cell type-independent but results in variable context-dependent functional effects. J Biol Chem 281 : 11992–12000.

27. ZhaoJ, ZhaoJ, PerlmanS (2012) Differential effects of IL-12 on Tregs and non-Treg T cells: roles of IFN-gamma, IL-2 and IL-2R. PLoS ONE 7: e46241.

28. TangQ, BluestoneJA (2006) Regulatory T-cell physiology and application to treat autoimmunity. Immunol Rev 212 : 217–237.

29. ShevachEM (2009) Mechanisms of foxp3+ T regulatory cell-mediated suppression. Immunity 30 : 636–645.

30. SarweenN, ChodosA, RaykundaliaC, KhanM, AbbasAK, et al. (2004) CD4+CD25+ cells controlling a pathogenic CD4 response inhibit cytokine differentiation, CXCR-3 expression, and tissue invasion. J Immunol 173 : 2942–2951.

31. KoeneckeC, LeeCW, ThammK, FohseL, SchafferusM, et al. (2012) IFN-gamma production by allogeneic Foxp3+ regulatory T cells is essential for preventing experimental graft-versus-host disease. J Immunol 189 : 2890–2896.

32. OldenhoveG, BouladouxN, WohlfertEA, HallJA, ChouD, et al. (2009) Decrease of Foxp3+ Treg cell number and acquisition of effector cell phenotype during lethal infection. Immunity 31 : 772–786.

33. KornT, ReddyJ, GaoW, BettelliE, AwasthiA, et al. (2007) Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat Med 13 : 423–431.

34. SunN, GrzybickiD, CastroR, MurphyS, PerlmanS (1995) Activation of astrocytes in the spinal cord of mice chronically infected with a neurotropic coronavirus. Virology 213 : 482–493.

35. Marek-TrzonkowskaN, MysliwiecM, DobyszukA, GrabowskaM, TechmanskaI, et al. (2012) Administration of CD4+CD25highCD127 -⁠ regulatory T cells preserves beta-cell function in type 1 diabetes in children. Diabetes Care 35 : 1817–1820.

36. TangQ, LeeK (2012) Regulatory T-cell therapy for transplantation: how many cells do we need? Curr Opin Organ Transplant 17 : 349–354.

37. FlemingJO, TrousdaleMD, El-ZaatariF, StohlmanSA, WeinerLP (1986) Pathogenicity of antigenic variants of murine coronavirus JHM selected with monoclonal antibodies. J Virol 58 : 869–875.

38. AnghelinaD, PeweL, PerlmanS (2006) Pathogenic role for virus-specific CD4 T cells in mice with coronavirus-induced acute encephalitis. Am J Pathol 169 : 209–222.

39. PeweL, ZhouH, NetlandJ, TangaduC, OlivaresH, et al. (2005) A severe acute respiratory syndrome-associated coronavirus-specific protein enhances virulence of an attenuated murine coronavirus. J Virol 79 : 11335–11342.

40. CastroRF, PerlmanS (1995) CD8+ T cell epitopes within the surface glycoprotein of a neurotropic coronavirus and correlation with pathogenicity. J Virol 69 : 8127–8131.

41. HaringJS, PeweLL, PerlmanS (2001) High-magnitude, virus-specific CD4 T-cell response in the central nervous system of coronavirus-infected mice. J Virol 75 : 3043–3047.